[Use of sympathetic beta inhibitors in cardiovascular disease].
D000787:Angina Pectoris / Q000188:drug therapy; D000818:Animals; D001014:Aortic Aneurysm / Q000188:drug therapy; D001145:Arrhythmias, Cardiac / Q000188:drug therapy; D001158:Arteries; D001281:Atrial Fibrillation / Q000188:drug therapy; D009202:Cardiomyopathies / Q000188:drug therapy; D002312:Cardiomyopathy, Hypertrophic / Q000188:drug therapy; D002318:Cardiovascular Diseases / Q000188:drug therapy*; D004071:Digitalis Glycosides / Q000506:poisoning; D006329:Heart Conduction System / Q000187:drug effects; D006331:Heart Diseases / Q000209:etiology; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D006980:Hyperthyroidism / Q000150:complications; D009203:Myocardial Infarction / Q000188:drug therapy; D010673:Pheochromocytoma / Q000188:drug therapy; D013565:Sympatholytics / Q000009:adverse effects / Q000627:therapeutic use*; D013610:Tachycardia / Q000188:drug therapy; D013614:Tachycardia, Paroxysmal / Q000188:drug therapy; D013771:Tetralogy of Fallot / Q000188:drug therapy
D004071:Digitalis Glycosides; D013565:Sympatholytics
Utilisation des inhibiteurs bêta du sympathique en pathologie cardio-vasculaire.